260 related articles for article (PubMed ID: 17420216)
1. Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
Lindberg R; Fredlund H; Nicholas R; Unemo M
Antimicrob Agents Chemother; 2007 Jun; 51(6):2117-22. PubMed ID: 17420216
[TBL] [Abstract][Full Text] [Related]
2. Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone.
Lee SG; Lee H; Jeong SH; Yong D; Chung GT; Lee YS; Chong Y; Lee K
J Antimicrob Chemother; 2010 Apr; 65(4):669-75. PubMed ID: 20093260
[TBL] [Abstract][Full Text] [Related]
3. Unique combined penA/mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population.
Thakur SD; Starnino S; Horsman GB; Levett PN; Dillon JR
J Antimicrob Chemother; 2014 Jun; 69(6):1510-6. PubMed ID: 24532681
[TBL] [Abstract][Full Text] [Related]
4. Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010.
Martin I; Sawatzky P; Allen V; Hoang L; Lefebvre B; Mina N; Wong T; Gilmour M
Sex Transm Dis; 2012 Apr; 39(4):316-23. PubMed ID: 22421701
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.
Lewis DA; Sriruttan C; Müller EE; Golparian D; Gumede L; Fick D; de Wet J; Maseko V; Coetzee J; Unemo M
J Antimicrob Chemother; 2013 Jun; 68(6):1267-70. PubMed ID: 23416957
[TBL] [Abstract][Full Text] [Related]
6. Emergence and Spread of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended-Spectrum Cephalosporins in Argentina, 2009 to 2013.
Gianecini R; Romero MLM; Oviedo C; Vacchino M; Galarza P;
Sex Transm Dis; 2017 Jun; 44(6):351-355. PubMed ID: 28499284
[TBL] [Abstract][Full Text] [Related]
7. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.
Unemo M; Golparian D; Nicholas R; Ohnishi M; Gallay A; Sednaoui P
Antimicrob Agents Chemother; 2012 Mar; 56(3):1273-80. PubMed ID: 22155830
[TBL] [Abstract][Full Text] [Related]
8. Cefixime and ceftriaxone susceptibility of Neisseria gonorrhoeae in Italy from 2006 to 2010.
Carannante A; Prignano G; Cusini M; Matteelli A; Dal Conte I; Ghisetti V; D'Antuono A; Cavrini F; Antonetti R; Stefanelli P
Clin Microbiol Infect; 2012 Jun; 18(6):558-64. PubMed ID: 21966997
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.
Li S; Su XH; Le WJ; Jiang FX; Wang BX; Rice PA
BMC Infect Dis; 2014 Nov; 14():622. PubMed ID: 25427572
[TBL] [Abstract][Full Text] [Related]
10. Neisseria gonorrhoeae antimicrobial susceptibility in Barcelona: penA, ponA, mtrR, and porB mutations and NG-MAST sequence types associated with decreased susceptibility to cephalosporins.
Serra-Pladevall J; Barberá MJ; Rodriguez S; Bartolomé-Comas R; Roig G; Juvé R; Andreu A
Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1549-56. PubMed ID: 27255221
[TBL] [Abstract][Full Text] [Related]
11. Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae.
Zhao S; Duncan M; Tomberg J; Davies C; Unemo M; Nicholas RA
Antimicrob Agents Chemother; 2009 Sep; 53(9):3744-51. PubMed ID: 19528266
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial resistance and molecular characterisation of Neisseria gonorrhoeae isolates in Fukuoka, Japan, 1996-2016.
Tanaka M; Furuya R; Kobayashi I; Kanesaka I; Ohno A; Katsuse AK
J Glob Antimicrob Resist; 2019 Jun; 17():3-7. PubMed ID: 30448519
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and Genotypic Characterization of
Jamaludin N; Gedye K; Collins-Emerson J; Benschop J; Nulsen M
Microb Drug Resist; 2019 Sep; 25(7):1003-1011. PubMed ID: 31021281
[No Abstract] [Full Text] [Related]
14. Genetic Resistance Determinants for Cefixime and Molecular Analysis of Gonococci Isolated in Italy.
Carannante A; Vacca P; Ghisetti V; Latino MA; Cusini M; Matteelli A; Vocale C; Prignano G; Leli C; Ober P; Antonetti R; Poletti F; Stefanelli P
Microb Drug Resist; 2017 Mar; 23(2):247-252. PubMed ID: 27347854
[TBL] [Abstract][Full Text] [Related]
15. Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone.
Osaka K; Takakura T; Narukawa K; Takahata M; Endo K; Kiyota H; Onodera S
J Infect Chemother; 2008 Jun; 14(3):195-203. PubMed ID: 18574654
[TBL] [Abstract][Full Text] [Related]
16. Ceftriaxone susceptibility and molecular characteristics of Neisseria gonorrhoeae isolates in Changsha, China.
Peng T; Lin H; Liu Q; Cao W; Ding H; Chen J; Tang L
J Infect Chemother; 2017 Jun; 23(6):385-389. PubMed ID: 28446378
[TBL] [Abstract][Full Text] [Related]
17. Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype.
Tanaka M; Nakayama H; Huruya K; Konomi I; Irie S; Kanayama A; Saika T; Kobayashi I
Int J Antimicrob Agents; 2006 Jan; 27(1):20-6. PubMed ID: 16318912
[TBL] [Abstract][Full Text] [Related]
18. Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is associated with mutations G542S, P551S and P551L in the gonococcal penicillin-binding protein 2.
Whiley DM; Goire N; Lambert SB; Ray S; Limnios EA; Nissen MD; Sloots TP; Tapsall JW
J Antimicrob Chemother; 2010 Aug; 65(8):1615-8. PubMed ID: 20511367
[TBL] [Abstract][Full Text] [Related]
19. Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations.
Tomberg J; Unemo M; Davies C; Nicholas RA
Biochemistry; 2010 Sep; 49(37):8062-70. PubMed ID: 20704258
[TBL] [Abstract][Full Text] [Related]
20. penA profile of Neisseria gonorrhoeae in Guangdong, China: Novel penA alleles are related to decreased susceptibility to ceftriaxone or cefixime.
Liao Y; Xie Q; Yin X; Li X; Xie J; Wu X; Tang S; Liu M; Zeng L; Pan Y; Yang J; Feng Z; Qin X; Zheng H
Int J Antimicrob Agents; 2024 Apr; 63(4):107101. PubMed ID: 38325722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
